These results may be associated with the downregulation of Klk6 expression (Figure 4E), which encodes a protease that cleaves the amyloid precursor protein and alpha‐synuclein, potentially implicated in Alzheimer's and Parkinson's disease, respectively [52, 53]. This evidence concerns the gene APP and Parkinson disease.